Home delivery of antiretroviral therapy amidst insecurity and COVID-19 Challenges in Nigeria

HOME DELIVERY OF ANTIRETROVIRALS FOR HIV CLIENTS AMIDST INSECURITY AND COVID-19 CHALLENGES: A PROTOCOL FOR A RANDOMIZED CONTROLLED TRIAL.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202004535536808

Enrollment

264

Registered

2020-04-08

Start date

2020-06-20

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Interventions

Home Delivery of Antiretrovirals

Facility Delivery of Antiretroviral

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: i) Age = 18years ii) Stable patients who commenced ART for = 6months and have suppressed viral load iii) Reside within the State iv) Give informed consent

Exclusion criteria

Exclusion criteria: i) Pregnancy at time of the enrollment ii) Age 20 copies /mil) vi) Withdrawal of consent vii) Reside outside the state

Design outcomes

Primary

Measure	Time frame
Difference between the HIV viral loads of the two groups (= 20 copies /ml	—

Secondary

Measure	Time frame
The cost incurred in delivering care in both arms;Cost-effectiveness of home based delivery compared to facilty based delivery;Client satisfaction with the services .;Willingness-to-pay for home based delivery;Adherence	—

Countries

Nigeria

Contacts

Public ContactEkwunife Obinna

Senior Lecturer

oi.ekwunife@unizik.ng234706232501

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026